Literature DB >> 28285023

Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).

Jonathan Rabinowitz1, Nina R Schooler2, Ariana Anderson3, Lindsay Ayearst4, David Daniel5, Michael Davidson6, Anzalee Khan7, Bruce Kinon8, Francois Menard9, Lewis Opler10, Mark Opler11, Joanne B Severe12, David Williamson13, Christian Yavorsky14, Jun Zhao15.   

Abstract

International Society for CNS Clinical Trials and Methodology convened an expert working-group that assembled consistency/inconsistency flags for the Positive and Negative Syndrome Scale (PANSS). Twenty-four flags were identified and divided based on extent to which they represent error (Possibly, Probably, Very probably or definitely). The flags were applied to assessments derived from the NEWMEDS data repository and the CATIE clinical trial data. Almost 40% of ratings had at least one inconsistency flag raised and 10% had two. Application of flags to clinical rating can improve reliability and validity of trials.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28285023      PMCID: PMC5662474          DOI: 10.1016/j.schres.2017.03.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

2.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

3.  DSM and the death of phenomenology in america: an example of unintended consequences.

Authors:  Nancy C Andreasen
Journal:  Schizophr Bull       Date:  2006-12-07       Impact factor: 9.306

4.  Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials.

Authors:  Jonathan Rabinowitz; Nomi Werbeloff; Ivo Caers; Francine S Mandel; Virginia Stauffer; François Ménard; Bruce J Kinon; Shitij Kapur
Journal:  J Clin Psychiatry       Date:  2014-04       Impact factor: 4.384

  4 in total
  4 in total

Review 1.  Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions.

Authors:  Mark G A Opler; Christian Yavorsky; David G Daniel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

2.  Association of APOE E2 and low-density lipoprotein with depressive symptoms in Chinese senile schizophrenia inpatients: A cross-sectional study.

Authors:  Wei Li
Journal:  Schizophr Res Cogn       Date:  2020-11-19

3.  The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods.

Authors:  Marc S Tibber; James B Kirkbride; Eileen M Joyce; Stanley Mutsatsa; Isobel Harrison; Thomas R E Barnes; Vyv Huddy
Journal:  Psychiatry Res       Date:  2018-10-30       Impact factor: 3.222

4.  Homozygosity in the APOE 3 Polymorphism Is Associated With Less Depression and Higher Serum Low-Density Lipoprotein in Chinese Elderly Schizophrenics.

Authors:  Wei Li; Chunxia Ban; Ling Yue; Lin Sun; Xia Li; Shifu Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-15       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.